APO RESEARCH · REPORT
Stem Cells
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Product & engineering
Understand the product.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Selected research
Industry Research
Stem Cells Industry Research Report 2026
Market perspective
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Scope
Read the full market overview
This report quantifies the global Stem Cells market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Stem Cells.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stem Cells Market by Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells Segment by Application
Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Storage
- Stem Cell Pharmaceutical and Treatment
Applications
- Diseases of the Central Nervous System
- Cardiovascular Disease
- Diabetes
- Cancer
- Genetic Diseases
- Autoimmune Disease
- Bone and Cartilage Repair
- Other
Companies covered
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- Medi-post
- JCR Pharmaceutical
- MolMed
- Pharmicell
- Anterogen
- Takeda (TiGenix)
- CBR
- ViaCord
- Esperite
- LifeCell
- CCBC
- VCANBIO
- BOYA LIFE
- Beike Biotechnology
- International Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Stem Cells by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cell Storage
- 2.2.3 Stem Cell Pharmaceutical and Treatment
- 2.3 Stem Cells by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diseases of the Central Nervous System
- 2.3.3 Cardiovascular Disease
- 2.3.4 Diabetes
- 2.3.5 Cancer
- 2.3.6 Genetic Diseases
- 2.3.7 Autoimmune Disease
- 2.3.8 Bone and Cartilage Repair
- 2.3.9 Other
- 2.4 Assumptions and Limitations
3 Stem Cells Breakdown Data by Type
- 3.1 Global Stem Cells Historic Market Size by Type (2021-2026)
- 3.2 Global Stem Cells Forecasted Market Size by Type (2027-2032)
4 Stem Cells Breakdown Data by Application
- 4.1 Global Stem Cells Historic Market Size by Application (2021-2026)
- 4.2 Global Stem Cells Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Stem Cells Market Perspective (2021-2032)
- 5.2 Global Stem Cells Growth Trends by Region
- 5.2.1 Global Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Stem Cells Historic Market Size by Region (2021-2026)
- 5.2.3 Stem Cells Forecasted Market Size by Region (2027-2032)
- 5.3 Stem Cells Market Dynamics
- 5.3.1 Stem Cells Industry Trends
- 5.3.2 Stem Cells Market Drivers
- 5.3.3 Stem Cells Market Challenges
- 5.3.4 Stem Cells Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Stem Cells Players by Revenue
- 6.1.1 Global Top Stem Cells Players by Revenue (2021-2026)
- 6.1.2 Global Stem Cells Revenue Market Share by Players (2021-2026)
- 6.2 Global Stem Cells Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Stem Cells Head Office and Area Served
- 6.4 Global Stem Cells Players, Product Type & Application
- 6.5 Global Stem Cells Manufacturers Established Date
- 6.6 Global Stem Cells Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Stem Cells Market Size (2021-2032)
- 7.2 North America Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Stem Cells Market Size by Country (2021-2026)
- 7.4 North America Stem Cells Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Stem Cells Market Size (2021-2032)
- 8.2 Europe Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Stem Cells Market Size by Country (2021-2026)
- 8.4 Europe Stem Cells Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cells Market Size (2021-2032)
- 9.2 Asia-Pacific Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Stem Cells Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Stem Cells Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Stem Cells Market Size (2021-2032)
- 10.2 South America Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Stem Cells Market Size by Country (2021-2026)
- 10.4 South America Stem Cells Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cells Market Size (2021-2032)
- 11.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Stem Cells Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Stem Cells Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Osiris Therapeutics
- 12.1.1 Osiris Therapeutics Company Information
- 12.1.2 Osiris Therapeutics Business Overview
- 12.1.3 Osiris Therapeutics Revenue in Stem Cells Business (2021-2026)
- 12.1.4 Osiris Therapeutics Stem Cells Product Portfolio
- 12.1.5 Osiris Therapeutics Recent Developments
- 12.2 NuVasive
- 12.2.1 NuVasive Company Information
- 12.2.2 NuVasive Business Overview
- 12.2.3 NuVasive Revenue in Stem Cells Business (2021-2026)
- 12.2.4 NuVasive Stem Cells Product Portfolio
- 12.2.5 NuVasive Recent Developments
- 12.3 Chiesi Pharmaceuticals
- 12.3.1 Chiesi Pharmaceuticals Company Information
- 12.3.2 Chiesi Pharmaceuticals Business Overview
- 12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2021-2026)
- 12.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
- 12.3.5 Chiesi Pharmaceuticals Recent Developments
- 12.4 Medi-post
- 12.4.1 Medi-post Company Information
- 12.4.2 Medi-post Business Overview
- 12.4.3 Medi-post Revenue in Stem Cells Business (2021-2026)
- 12.4.4 Medi-post Stem Cells Product Portfolio
- 12.4.5 Medi-post Recent Developments
- 12.5 JCR Pharmaceutical
- 12.5.1 JCR Pharmaceutical Company Information
- 12.5.2 JCR Pharmaceutical Business Overview
- 12.5.3 JCR Pharmaceutical Revenue in Stem Cells Business (2021-2026)
- 12.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
- 12.5.5 JCR Pharmaceutical Recent Developments
- 12.6 MolMed
- 12.6.1 MolMed Company Information
- 12.6.2 MolMed Business Overview
- 12.6.3 MolMed Revenue in Stem Cells Business (2021-2026)
- 12.6.4 MolMed Stem Cells Product Portfolio
- 12.6.5 MolMed Recent Developments
- 12.7 Pharmicell
- 12.7.1 Pharmicell Company Information
- 12.7.2 Pharmicell Business Overview
- 12.7.3 Pharmicell Revenue in Stem Cells Business (2021-2026)
- 12.7.4 Pharmicell Stem Cells Product Portfolio
- 12.7.5 Pharmicell Recent Developments
- 12.8 Anterogen
- 12.8.1 Anterogen Company Information
- 12.8.2 Anterogen Business Overview
- 12.8.3 Anterogen Revenue in Stem Cells Business (2021-2026)
- 12.8.4 Anterogen Stem Cells Product Portfolio
- 12.8.5 Anterogen Recent Developments
- 12.9 Takeda (TiGenix)
- 12.9.1 Takeda (TiGenix) Company Information
- 12.9.2 Takeda (TiGenix) Business Overview
- 12.9.3 Takeda (TiGenix) Revenue in Stem Cells Business (2021-2026)
- 12.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
- 12.9.5 Takeda (TiGenix) Recent Developments
- 12.10 CBR
- 12.10.1 CBR Company Information
- 12.10.2 CBR Business Overview
- 12.10.3 CBR Revenue in Stem Cells Business (2021-2026)
- 12.10.4 CBR Stem Cells Product Portfolio
- 12.10.5 CBR Recent Developments
- 12.11 ViaCord
- 12.11.1 ViaCord Company Information
- 12.11.2 ViaCord Business Overview
- 12.11.3 ViaCord Revenue in Stem Cells Business (2021-2026)
- 12.11.4 ViaCord Stem Cells Product Portfolio
- 12.11.5 ViaCord Recent Developments
- 12.12 Esperite
- 12.12.1 Esperite Company Information
- 12.12.2 Esperite Business Overview
- 12.12.3 Esperite Revenue in Stem Cells Business (2021-2026)
- 12.12.4 Esperite Stem Cells Product Portfolio
- 12.12.5 Esperite Recent Developments
- 12.13 LifeCell
- 12.13.1 LifeCell Company Information
- 12.13.2 LifeCell Business Overview
- 12.13.3 LifeCell Revenue in Stem Cells Business (2021-2026)
- 12.13.4 LifeCell Stem Cells Product Portfolio
- 12.13.5 LifeCell Recent Developments
- 12.14 CCBC
- 12.14.1 CCBC Company Information
- 12.14.2 CCBC Business Overview
- 12.14.3 CCBC Revenue in Stem Cells Business (2021-2026)
- 12.14.4 CCBC Stem Cells Product Portfolio
- 12.14.5 CCBC Recent Developments
- 12.15 VCANBIO
- 12.15.1 VCANBIO Company Information
- 12.15.2 VCANBIO Business Overview
- 12.15.3 VCANBIO Revenue in Stem Cells Business (2021-2026)
- 12.15.4 VCANBIO Stem Cells Product Portfolio
- 12.15.5 VCANBIO Recent Developments
- 12.16 BOYA LIFE
- 12.16.1 BOYA LIFE Company Information
- 12.16.2 BOYA LIFE Business Overview
- 12.16.3 BOYA LIFE Revenue in Stem Cells Business (2021-2026)
- 12.16.4 BOYA LIFE Stem Cells Product Portfolio
- 12.16.5 BOYA LIFE Recent Developments
- 12.17 Beike Biotechnology
- 12.17.1 Beike Biotechnology Company Information
- 12.17.2 Beike Biotechnology Business Overview
- 12.17.3 Beike Biotechnology Revenue in Stem Cells Business (2021-2026)
- 12.17.4 Beike Biotechnology Stem Cells Product Portfolio
- 12.17.5 Beike Biotechnology Recent Developments
- 12.18 International Medical
- 12.18.1 International Medical Company Information
- 12.18.2 International Medical Business Overview
- 12.18.3 International Medical Revenue in Stem Cells Business (2021-2026)
- 12.18.4 International Medical Stem Cells Product Portfolio
- 12.18.5 International Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst